Burden of tuberculosis &amp; malaria among tribal populations &amp; implications for disease elimination in India

Narain, Jai Prakash; Shah, Amar N; Bhatia, Rajesh

doi:10.4103/ijmr.ijmr_2128_22

Cited by 2 publications

(12 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,3,4,20,38,41,46,54,55 In fact, many PTB patients used dangerous sputum disposal techniques, which are dominant in male and illiterate patients from lower socioeconomic groups. 1,22,31,[41][42][43][44]56 Fig. 6.…”

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

“…Despite this difficult situation, India is committed to eliminating TB by 2025, with the assistance of the National Tuberculosis Elimination Program (NTEP), which collects the majority of TB statistics in India and was previously called the RNTCP. 22,[48][49][50][51][52][53] According to the National Tuberculosis Report (2023), Kerala, Tamil Nadu, Assam, and Uttar Pradesh are the states that performed relatively better in terms of TB elimination than the majority of states in India in 2022. 49 Regarding performance Kerala created the System for Workplace Engagement to Eliminate and stop the spread of TB among employers in a variety of workplaces and industries.…”

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

“…1,3,4,[10][11][12]20,28,38,41,43,46,59 Furthermore, the COVID-19 reaction-induced lockdown has resulted in poverty and economic hardship, worsening food shortages and making it more difficult to provide various TB services such as prevention, surveillance, and treatment to the vulnerable segment. 13,22,31,44,60 Children with TB had significant implications or problems during the COVID epidemic, such as requiring more mechanical breathing, being hospitalized for longer periods of time, and having poorer outcomes. 11,13,14 Scheduled Tribes represent 8.6% of India's population with having high TB prevalence (703 per 1,00,000) as compared to national TB average cases (256 per 1,00,000).…”

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

“…1,2 As a result, treating TB is costly, time-consuming, and has a low success rate. 1,2,[16][17][18][19][20][21][22] Co-morbidities that weaken the immune system and increase the risks of TB infection in people over a short period of time include undernutrition, diabetes, HIV, tobacco use, smoking, and alcohol consumption. 2,[21][22][23][24][25][26][27][28][29][30][31][32] M. tuberculosis also has a diverse pattern of region-specific prevalence and susceptibility, genetic mutation over time, space, and environment.…”

Section: Introductionmentioning

confidence: 99%

“…1,2,[16][17][18][19][20][21][22] Co-morbidities that weaken the immune system and increase the risks of TB infection in people over a short period of time include undernutrition, diabetes, HIV, tobacco use, smoking, and alcohol consumption. 2,[21][22][23][24][25][26][27][28][29][30][31][32] M. tuberculosis also has a diverse pattern of region-specific prevalence and susceptibility, genetic mutation over time, space, and environment. 23,33,34 Nearly one in every two TB patients' household contacts has latent TB, and the severity of the infection is related to the age of the household contacts.…”

Section: Introductionmentioning

confidence: 99%

See 4 more Smart Citations

Tuberculosis epidemic in India – a systematic review

Deotale,

Mondal

2023

Eur J Clin Exp Med

View full text Add to dashboard Cite

Introduction and aim. India, accounting for approximately 26% of the global tuberculosis (TB) burden with a significant proportion of 0.11 million (6%) pediatric TB cases. The goal of this systematic review paper is to provide a thorough analysis of the TB epidemic in India, including information on the severity of the illness and challenges associated with diagnosis and treatment, the risk factors for transmission and progression of the disease, and the advancements and difficulties encountered in efforts to control at community level. Material and methods. The terms “Tuberculosis in India,” “Drug-Resistant Tuberculosis,” “Tuberculosis and Associated Co-morbidities,” “Diagnosis of Tuberculosis,” “Prevention of Tuberculosis,” and “Treatment of Tuberculosis’’, keywords were used to search in number of international electronic databases, including “Google Scholar,” “PubMed,” and “DOAJ.” Analysis of the literature. Diagnosis and treatment of TB are significantly complicated by co-morbid condition such includes alcoholism, diabetes, HIV, undernutrition, diabetes and HIV. In addition, there may be treatment delays, and the extra-pulmonary or drug-resistant TB due to ignorance, misunderstandings, and lack of education among TB patients, and medical professionals, which ultimately increases morbidity and mortality. Conclusion. Poverty, undernutrition, inadequate healthcare infrastructure, and co-morbidities, which frequently complicate TB diagnosis and treatment, must be addressed in addition to the critical need to prioritize TB research and development.

show abstract

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

Section: The Burden Of Tuberculosis In Different States Of Indiamentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

See 3 more Smart Citations

Tuberculosis epidemic in India – a systematic review

Deotale,

Mondal

2023

Eur J Clin Exp Med

View full text Add to dashboard Cite

show abstract

Burden of Tuberculosis among tribal populations of India: A systematic review and meta-analysis

Debnath,

Singh,

Gupta

et al. 2024

Lung India

View full text Add to dashboard Cite

Tuberculosis (TB) continues to impose a significant burden on tribal populations in India, a high-risk group for the disease. Despite its preventable and curable nature, TB remains a formidable health challenge for these communities. However, a critical knowledge gap exists regarding the population-based prevalence of TB among tribal populations in India. The current systematic review and meta-analysis were carried out to provide a single, population-based estimate. A comprehensive search was conducted on PubMed, Embase, Scopus, and Web of Science databases using the keywords ‘tuberculosis’, ‘TB’, and ‘tribal’ or ‘tribes’. This search encompassed articles published between 1 January 2000 and 1 March 2023. The included articles underwent a quality assessment screening to ensure their reliability and relevance. Subsequently, a pooled estimate of TB prevalence among tribal populations was quantified using a random-effects model. To investigate potential sources of heterogeneity in the prevalence estimates, subgroup analyses were performed. We identified 14 studies that encompassed a substantial population of 267,377 individuals from various regions in India belonging to tribal communities. The application of a random-effects model yielded a pooled prevalence estimate of 894.4 per 100,000 population, with a 95% confidence interval ranging from 523.5 to 1361.9. The assessment of heterogeneity using the Cochrane Q test indicated significant variability among the included studies (I2 = 99.17%; P < 0.001). Notably, the prevalence of TB among tribal populations was found to be higher than the national prevalence. The scientific evidence available for the prevalence of TB among tribal populations is restricted to a few tribes only. Conducting further research to estimate the prevalence among other tribes all over the country is the need of the hour and should be addressed accordingly.

show abstract

Burden of tuberculosis & malaria among tribal populations & implications for disease elimination in India

Cited by 2 publications

References 8 publications

Tuberculosis epidemic in India – a systematic review

Tuberculosis epidemic in India – a systematic review

Burden of Tuberculosis among tribal populations of India: A systematic review and meta-analysis

Contact Info

Product

Resources

About